Douglas Lane & Associates LLC Cuts Position in Haleon PLC Sponsored ADR $HLN

Key Points

• Douglas Lane & Associates LLC cut its position in Haleon PLC (NYSE:HLN) by 17.2% in Q4, selling 1,405,621 shares and leaving it with 6,761,355 shares worth about $68.36 million (≈0.15% ownership).
• Analyst sentiment is mixed but broadly positive: the consensus rating is a “Moderate Buy” with a $12.33 average target (2 Strong Buy, 4 Buy, 2 Hold, 1 Sell).
• Haleon declared a $0.1307 dividend payable May 14 (record April 10); the stock trades near $10 with a 52‑week range of $8.71–$11.42 and a market cap around $44.6 billion.

Douglas Lane & Associates LLC decreased its holdings in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 17.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,761,355 shares of the company's stock after selling 1,405,621 shares during the quarter. Douglas Lane & Associates LLC owned about 0.15% of Haleon worth $68,357,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the company. Aaron Wealth Advisors LLC increased its position in shares of Haleon by 51.0% in the fourth quarter. Aaron Wealth Advisors LLC now owns 41,222 shares of the company's stock valued at $417,000 after buying an additional 13,922 shares in the last quarter. Leo Wealth LLC purchased a new stake in Haleon during the 4th quarter worth about $111,000. Ascent Group LLC increased its position in Haleon by 97.1% during the 4th quarter. Ascent Group LLC now owns 65,478 shares of the company's stock worth $662,000 after purchasing an additional 32,260 shares in the last quarter. Stratos Investment Management LLC purchased a new stake in Haleon during the 4th quarter worth about $125,000. Finally, Cromwell Holdings LLC increased its position in Haleon by 24.3% during the 4th quarter. Cromwell Holdings LLC now owns 12,060 shares of the company's stock worth $122,000 after purchasing an additional 2,357 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company's stock.

Analysts Set New Price Targets

A number of analysts have issued reports on HLN shares. Deutsche Bank Aktiengesellschaft lowered Haleon from a "hold" rating to a "sell" rating in a research note on Monday, January 12th. HSBC raised Haleon from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, January 21st. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Haleon in a research note on Thursday, January 22nd. Argus raised Haleon to a "strong-buy" rating in a research report on Tuesday, March 17th. Finally, Wall Street Zen raised Haleon from a "hold" rating to a "buy" rating in a research report on Saturday, March 21st. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $12.33.

Haleon Stock Performance

Shares of HLN opened at $10.00 on Friday. The business's 50 day moving average is $10.47 and its two-hundred day moving average is $9.90. Haleon PLC Sponsored ADR has a 52-week low of $8.71 and a 52-week high of $11.42. The firm has a market cap of $44.64 billion, a price-to-earnings ratio of 25.64 and a beta of 0.26. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 0.47.

Haleon (NYSE:HLN - Get Free Report) last announced its earnings results on Saturday, February 14th. The company reported $6.32 earnings per share (EPS) for the quarter. The business had revenue of $3.65 billion during the quarter. Analysts forecast that Haleon PLC Sponsored ADR will post 0.43 EPS for the current fiscal year.

Haleon Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, May 14th. Shareholders of record on Friday, April 10th will be given a $0.1307 dividend. This represents a dividend yield of 261.0%. The ex-dividend date of this dividend is Friday, April 10th. Haleon's dividend payout ratio is presently 28.21%.

Haleon Company Profile

Haleon plc NYSE: HLN is a global consumer healthcare company formed through the separation of a large pharmaceutical group's consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.